Search research articles
Contact Us
Filters
Showing results (171-180 of 189) with videos related to
Page
of 19
Sort By:
Menopause (New York, N.Y.)
|
September 8, 2005
Monitoring reproductive aging in a 5-year prospective study: aggregate and individual changes in steroid hormones and menstrual cycle lengths with age
Rebecca J Ferrell, Kathleen A O'Connor, Germán Rodríguez, et al.
The American Journal of Cardiology
|
July 7, 1999
Low- versus high-dose recombinant urokinase for the treatment of chronic saphenous vein graft occlusion
P S Teirstein, J T Mann, P E Cundey, et al.
Bioorganic & Medicinal Chemistry
|
June 16, 2009
Novel 1-aminoethyl-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines are potent 5-HT(6) agonists
Ronald C Bernotas, Steven Lenicek, Schuyler Antane, et al.
Journal of Medicinal Chemistry
|
October 12, 2010
5-Piperazinyl-3-sulfonylindazoles as potent and selective 5-hydroxytryptamine-6 antagonists
Kevin G Liu, Albert J Robichaud, Ronald C Bernotas, et al.
Journal of Medicinal Chemistry
|
July 21, 2006
Synthesis and biological evaluation of novel compounds within a class of 3-aminochroman derivatives with dual 5-HT1A receptor and serotonin transporter affinity
Nicole T Hatzenbuhler, Deborah A Evrard, Boyd L Harrison, et al.
American Heart Journal
|
April 27, 2000
Reduced thrombus burden with abciximab delivered locally before percutaneous intervention in saphenous vein grafts
G W Barsness, C Buller, E M Ohman, et al.
Bioorganic & Medicinal Chemistry
|
November 25, 2010
Identification of 3-sulfonylindazole derivatives as potent and selective 5-HT(6) antagonists
Kevin G Liu, Albert J Robichaud, Alexander A Greenfield, et al.
Journal of Medicinal Chemistry
|
May 13, 2005
Synthesis and biological evaluation of benzodioxanylpiperazine derivatives as potent serotonin 5-HT(1A) antagonists: the discovery of Lecozotan
Wayne E Childers, Magid A Abou-Gharbia, Michael G Kelly, et al.
British Journal of Pharmacology
|
April 3, 2009
Preclinical characterization of WAY-211612: a dual 5-HT uptake inhibitor and 5-HT (1A) receptor antagonist and potential novel antidepressant
C E Beyer, Q Lin, B Platt, et al.
Science Translational Medicine
|
September 1, 2017
Inflammatory monocytes expressing tissue factor drive SIV and HIV coagulopathy
Melissa E Schechter, Bruno B Andrade, Tianyu He, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 189) with videos related to
Sort By:
Page
of 19
Menopause (New York, N.Y.)
|
September 8, 2005
Monitoring reproductive aging in a 5-year prospective study: aggregate and individual changes in steroid hormones and menstrual cycle lengths with age
Rebecca J Ferrell, Kathleen A O'Connor, Germán Rodríguez, et al.
The American Journal of Cardiology
|
July 7, 1999
Low- versus high-dose recombinant urokinase for the treatment of chronic saphenous vein graft occlusion
P S Teirstein, J T Mann, P E Cundey, et al.
Bioorganic & Medicinal Chemistry
|
June 16, 2009
Novel 1-aminoethyl-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines are potent 5-HT(6) agonists
Ronald C Bernotas, Steven Lenicek, Schuyler Antane, et al.
Journal of Medicinal Chemistry
|
October 12, 2010
5-Piperazinyl-3-sulfonylindazoles as potent and selective 5-hydroxytryptamine-6 antagonists
Kevin G Liu, Albert J Robichaud, Ronald C Bernotas, et al.
Journal of Medicinal Chemistry
|
July 21, 2006
Synthesis and biological evaluation of novel compounds within a class of 3-aminochroman derivatives with dual 5-HT1A receptor and serotonin transporter affinity
Nicole T Hatzenbuhler, Deborah A Evrard, Boyd L Harrison, et al.
American Heart Journal
|
April 27, 2000
Reduced thrombus burden with abciximab delivered locally before percutaneous intervention in saphenous vein grafts
G W Barsness, C Buller, E M Ohman, et al.
Bioorganic & Medicinal Chemistry
|
November 25, 2010
Identification of 3-sulfonylindazole derivatives as potent and selective 5-HT(6) antagonists
Kevin G Liu, Albert J Robichaud, Alexander A Greenfield, et al.
Journal of Medicinal Chemistry
|
May 13, 2005
Synthesis and biological evaluation of benzodioxanylpiperazine derivatives as potent serotonin 5-HT(1A) antagonists: the discovery of Lecozotan
Wayne E Childers, Magid A Abou-Gharbia, Michael G Kelly, et al.
British Journal of Pharmacology
|
April 3, 2009
Preclinical characterization of WAY-211612: a dual 5-HT uptake inhibitor and 5-HT (1A) receptor antagonist and potential novel antidepressant
C E Beyer, Q Lin, B Platt, et al.
Science Translational Medicine
|
September 1, 2017
Inflammatory monocytes expressing tissue factor drive SIV and HIV coagulopathy
Melissa E Schechter, Bruno B Andrade, Tianyu He, et al.
Page
of 19